Affiliation:
1. Miami Veterans Affairs Hospital, Miami, FL; and
2. Bascom Palmer Eye Institute, Miami, FL
Abstract
Purpose:
To report a successfully managed case of idiopathic Fusarium sclerouveitis in a healthy patient with no identifiable risk factors.
Methods:
We describe a case of a 79-year-old man who presented with right-sided eye, facial, and head pain. Initial examination revealed temporal scleral thinning, inflammation, and anterior chamber cell/flare. Cultures were positive for Fusarium species.
Results:
The patient was treated with sub-Tenon amphotericin, intrascleral voriconazole, surgical debridement, Rose Bengal photodynamic therapy, systemic voriconazole and posaconazole, and topical natamycin. The infection resolved and the patient's visual acuity improved to 20/40.
Conclusions:
Fusarium sclerouveitis can occur without clear risk factors. This case highlights the importance of an aggressive, multimodal treatment approach for successful management.
Funder
U.S. Department of Veterans Affairs
Biomedical Laboratory Research and Development, VA Office of Research and Development
Rehabilitation Research and Development Service
Clinical Science Research and Development
U.S. Department of Defense
National Eye Institute
NATIONAL EYE INSTITUTE
NIH Clinical Center
Research to Prevent Blindness
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference12 articles.
1. Occult fungal scleritis;Jeang;Ocul Oncol Pathol,2017
2. Immune privilege: the microbiome and uveitis;Mölzer;Front Immunol,2020
3. Epidemiology and visual outcomes in patients with infectious scleritis;Hodson;Cornea,2013
4. Clinical characteristics and visual outcomes in infectious scleritis: a review;Ramenaden;Clin Ophthalmol,2013
5. Determinants of clinical outcomes after infectious scleritis;Oh;Cornea,2023